The study, "Use of Florbetapir-PET for Imaging beta-amyloid Pathology," has been selected by the Alzheimer's Association as the winner of the 2011 de Leon Prize in Neuroimaging for the "Best Paper" in human neuroimaging, in the Senior Scientist category.
A report by the National Research Council presents a new framework for K-12 science education that identifies the key scientific ideas and practices all students should learn by the end of high school.
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma.
Van Andel Research Institute (VARI) scientists demonstrated how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.
The three-month data from a Phase 2 study showed that treatment of adults with nonsense mutation cystic fibrosis (nmCF) with PTC Therapeutics Inc.’s ataluren resulted in improvements in chloride channel activity, CF-related cough, and positive trends in lung function.
Allon Therapeutics Inc. announced findings that 12 weeks of treatment with its lead product davunetide appears to prevent cortical thinning of important parts of the brains of schizophrenia patients.
QIAGEN launches the Multiplex PCR Plus Kit, designed for rapid and sensitive multiplex PCR that allows researchers to amplify several targets in one PCR run.
Thermo Fisher Scientific Inc. announced its Nunc online plate selector guide, a tool for users to select the correct plate format for their applications. Choosing the right plate surface can optimize resulting data while increasing lab efficiency.
Malvern Instruments Ltd and Paraytec Ltd have entered into a development and licensing agreement that will see Paraytec’s ActiPix technology being added to Malvern’s materials characterization portfolio.
There are few drug companies who haven’t experienced the pain of dumping millions of dollars and years of research into a compound that ultimately isn’t viable.
Talon Therapeutics, Inc. announced the submission of a New Drug Application for Marqibo to the FDA. Talon is seeking accelerated approval of Marqibo in adult Ph- ALL, in second or greater relapse.
Pfizer Inc. says it's reached a definitive agreement to buy Icagen, a small biopharmaceutical company that specializes in developing pain treatments. The deal could boost Pfizer's portfolio in one of its priority research areas.
Drug and medical device maker Abbott Laboratories reported a 48 percent jump in its second-quarter profit on lower expenses and a one-time tax benefit.
The majority of advisers on a federal health panel say a first-of-a-kind diabetes drug that uses a new method to reduce blood sugar shouldn't be approved for U.S. patients after higher rates of bladder and breast cancer were reported.
EMD Millipore’s NovaSeptum 60 mL bottle allows for the measurement of larger sample sizes than currently available syringe configurations. The sterile, closed, disposable system is used for sterile sampling of manufacturing processes.